Top 10 most productive workforces in biopharma
FiercePharma analyzed productivity at major pharma and biotech companies by measuring revenue per employee in 2016 (the most recent numbers available), and they found a winning formula: Sell a top drug with a relatively small team. For Gilead Sciences, that’s its hepatitis C franchise; for Celgene, that’s Revlimid; for Biogen, it’s multiple sclerosis. See who else made the top 10:
1. Gilead Sciences
2016 employees: 9,000
2016 revenues: $30.39 billion
Revenue per employee: $3.37 million
2. Celgene
2016 employees: 7,132
2016 revenues: $11.23 billion
Revenue per employee: $1.57 million
3. Biogen
2016 employees: 7,400
2016 revenues: $11.45 billion
Revenue per employee: $1.55 million
4. Amgen
2016 employees: 19,200
2016 revenues: $22.99 billion
Revenue per employee: $1.20 million
5. Allergan
2016 employees: 16,700
2016 revenues: $14.57 billion
Revenue per employee: $0.87 million
6. AbbVie
2016 employees: 30,000
2016 revenues: $25.64 billion
Revenue per employee: $0.85 million
7. Bristol-Myers Squibb
2016 employees: 25,000
2016 revenues: $19.43 billion
Revenue per employee: $0.78 million
8. Merck & Co.
2016 employees: 68,000
2016 revenues: $39.81 billion
Revenue per employee: $0.59 million
9. Johnson & Johnson
2016 employees: 126,400
2016 revenues: $71.89 billion
Revenue per employee: $0.57 million
10. Pfizer
2016 employees: 96,500
2016 revenues: $52.82 billion
Revenue per employee: $0.55 million
